Award
National Institute on Drug Abuse 5R01DA059874-02
Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis
Recipient
National Institute on Drug Abuse (NIDA), NIH, US
Award Amount
$879,451.00
Ceiling
$879,451.00
Awarded
February 20, 2026
Identifier
5R01DA059874-02
Research award to study cannabinoid effects on CNS inflammasome activation via the gut-brain axis, aiming to develop targeted anti-inflammatory therapies in HIV/SIV infection.
Description
The project involves studying the effects of cannabinoids on inflammasome activation in HIV/SIV infection. The award is part of a research effort to develop targeted anti-inflammatory therapies. The project duration is from April 15, 2025, to February 28, 2030.